Novel 2-(Adamantan-1-ylamino)Thiazol-4(5<i>H</i>)-One Derivatives and Their Inhibitory Activity towards 11β-HSD1—Synthesis, Molecular Docking and In Vitro Studies
A common mechanism in which glucocorticoids participate is suggested in the pathogenesis of such metabolic diseases as obesity, metabolic syndrome, or Cushing’s syndrome. The enzyme involved in the control of the availability of cortisol, the active form of the glucocorticoid for the glucocorticoid...
Main Authors: | Renata Studzińska, Daria Kupczyk, Wojciech Płaziński, Szymon Baumgart, Rafał Bilski, Renata Paprocka, Renata Kołodziejska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8609 |
Similar Items
-
Synthesis of Novel 2-(Isopropylamino)thiazol-4(5<i>H</i>)-one Derivatives and Their Inhibitory Activity of 11β-HSD1 and 11β-HSD2 in Aspect of Carcinogenesis Prevention
by: Daria Kupczyk, et al.
Published: (2020-09-01) -
A Novel <i>N-Tert</i>-Butyl Derivatives of Pseudothiohydantoin as Potential Target in Anti-Cancer Therapy
by: Daria Kupczyk, et al.
Published: (2021-04-01) -
Hydroxysteroid dehydrogenase HSD1L is localised to the pituitary–gonadal axis of primates
by: A Daniel Bird, et al.
Published: (2017-09-01) -
11β-HSD Types 1 and 2 in the Songbird Brain
by: Michelle A. Rensel, et al.
Published: (2018-03-01) -
Étude de l'action du PBRM, un inhibiteur de la 17β-hydroxystéroïde déshydrogénase (17β--HSD) type 1 : ...qui mena à la découverte fortuite d'un 1er activateur de la 17β-HSD type 12
by: Trottier, Alexandre
Published: (2014)